Skip to main content

Day: March 9, 2022

Commissioning of photovoltaic projects in Greece with a capacity of 12 megawatts

Voltalia (Euronext Paris ISIN code: FR0011995588), an international player in renewable energies, announces today that it has commissioned its Stavria solar power plant, located in Korythio, within the municipality of Tripoli in the Peloponnese region. In the tender launched in October 2020 by the Greek Energy Regulatory Authority, Voltalia won from twenty-year power sale contracts for five photovoltaic projects, totaling 12 megawatts located on a 25.3 hectare site. It consists of 22,242 solar panels, and its production will cover the domestic electricity needs of 21,220 inhabitants. Voltalia owns and operates 36 solar power plants in Greece for a total of 16.7 megawatts. Voltalia also provides construction, operations and maintenance services to third-party customers, with nearly 100 megawatts currently under contract. In addition, Voltalia...

Continue reading

Eurobio Scientific launches new proprietary test for the detection of Omicron BA.x, BA.2 and Delta variants of SARS-CoV-2

Eurobio Scientific launches new proprietary test for the detection of Omicron BA.x, BA.2 and Delta variants of SARS-CoV-2Routine COVID screening test that simultaneously detects and identifies the presence of Omicron BA.x, Omicron BA.2 and screens for other Delta variants First French test for screening for Omicron and Delta variants requiring only one reaction and delivering a result in 45 minutesParis, March 9, 2022 – 18:15 pm Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in specialty in vitro medical diagnostics, announces the RUO (Research Use Only) launch of a new proprietary test, EBX 048, Eurobioplex SARS-CoV-2 Fast-SVT (Screening and VOC1 Typing), developed́ specifically for routine COVID-19 screening and identification of current variants. The proprietary EBX SARS-CoV-2 Fast-SVT is a real-time...

Continue reading

Medical Linen Provider Has Record-Breaking Year in National Growth

The national textile provider, ImageFIRST, continued rapid expansion in 2021, grows National Account divisionImageFIRST Linen Delivery Trucks ImageFIRST linen delivery trucks outside of one of their laundry plants.King of Prussia, PA, March 09, 2022 (GLOBE NEWSWIRE) — ImageFIRST, the largest national provider of linen and laundry services for the healthcare industry, announced today that they achieved record-breaking growth in 2021. The textile provider added more than 10 facilities through acquisitions in 2021 – stretching across the nation from Maine to Seattle. To support their growth, ImageFIRST expanded its National Account division to enhance its capabilities to support more multiregional accounts. The healthcare linen provider entered multiple new states and regions in 2021, including South Texas, Maine, Minnesota, and...

Continue reading

SMCP – 2021 Full-Year Results

2021 Full Year ResultsPress release – Paris, March 9th, 2022 Sales exceed one-billion-euro mark againImproving trend leading to a dynamic and highly profitable yearQ4 Sales at par with pre-pandemic levelsQ4 Sales at par with 2019 level thanks to a gradual improvement throughout the year, up +22.1% on an organic1 basis vs. 2020 2021 Sales at €1,038.6m, up +18.7% on an organic basis vs. 2020 (driven by a LFL2 growth of +16.7%), and down -9.7% on an organic basis vs. 2019, despite the impact of the pandemic, still with limited tourism and promotional sales deliberately reduced Sales momentum in 2021 driven by the APAC region with Mainland China growing strongly compared to 2019 (+15.2%3 on an organic basis), and the Americas back to 2019 level thanks to the United States outperformance (+5.5% vs. 2019 on an organic basis) Very strong...

Continue reading

Neurones: 7.4% net profit in 2021

PRESS INFORMATIONHeading: 2021 annual results        Nanterre, March 9, 2022 (after trading) 7.4% net profit in 2021Accounts as at December 31 (audited and in €m) 2019 2020 2021Revenues 510.1 524.5 579.9Business operating profit (1) 54.7 (10.7%) 53.9 (10.3%) 64.2 (11.1%)Operating profit 53.7 (10.5%) 51.9 (9.9%) 61.6 (10.6%)Net financial profit 0.1 1.7 0.2Income tax (18.6) (18.6) (18.8)Net profit 35.2 (6.9%) 35 (6.7%) 42.9 (7.4%)– of which, group share 30.8 30.9 37.7Free cash flow (2) 47 55.2 51.8Cash and cash equivalents (net of financial debt) (3) 218.3 265.9 264.6Staff at year-end 5,372 5,589 5,869(1)        Prior to cost of bonus shares and impairment of assets.(2)        Cash flow from operational activities, plus financial profit and less net industrial investments.(3)        Excluding IFRS16...

Continue reading

Decisions by the Board of Directors of Evli Bank Plc on March 9, 2022

EVLI BANK PLC STOCK EXCHANGE RELEASE MARCH 9, 2022 AT 6.30 PM. (EET/EEST) On March 9, 2022, Evli Bank Plc’s Annual General Meeting confirmed the total number of members of Evli Bank Plc’s Board of Directors as five (5). Henrik Andersin, Fredrik Hacklin, Sari Helander, Robert Ingman and Teuvo Salminen were re-elected as members of the Board. The term of the Board of Directors ends in connection with the partial demerger of Evli Bank Plc and the merger of Evli Bank Plc and Fellow Finance Plc, which is scheduled for April 2, 2022. On March 9, 2022, the organizational meeting of the Board of Directors elected from among its members Henrik Andersin as its Chairman and Teuvo Salminen as its Vice Chairman. Teuvo Salminen was elected Chairman and Robert Ingman and Fredrik Hacklin as members of the Audit Committee. Sari Helander was...

Continue reading

Rapala VMC Corporation: Share repurchase 9.3.2022

Rapala VMC Corporation Stock Exchange Release 9.3.2022          RAPALA VMC CORPORATION: Share repurchase 9.3.2022     In the NASDAQ OMX Helsinki         Trade date 9.3.2022  Bourse trade Buy  Share RAP1V  Amount 4,000 SharesAverage price/ share 6,3925 EURTotal cost 25,570.00 EUR          Company now holds a total of 86 135 shares  including the shares repurchased on 9.3.2022            On behalf of Rapala VMC Corporation       Nordea Bank Finland Plc         Janne Sarvikivi Sami Huttunen                 For further information:    Olli Aho    Investor Relations, tel. +358 9 7562 540       www.rapalavmc.com       AttachmentRAP1V_9.3_trades

Continue reading

Ålandsbanken Abp: Acquisitions of own shares 09.03.2022

Ålandsbanken Abp  Changes in company’s own shares09.03.2022 at 18:30 EET Ålandsbanken Abp: Acquisitions of own shares 09.03.2022Date 09.03.2022  ExchangeBourse trade   Nasdaq Helsinki Oy (XHEL)Buy  Share class ALBBV  Amount             1,900  Average price/share 32.4895 EURHighest price/share 32.5000 EURLowest price/share 32.4000 EURTotal price 61,730.05 EUR     The shares held by Ålandsbanken Abp on 09.03.2022:    ALBBV  32,328  On behalf of Ålandsbanken Abp Skandinaviska Enskilda Banken AB (Publ) Antti Salakka                      Janne Tiihonen For more information, please contact: Peter Wiklöf, Managing Director and Chief Executive, Bank of Åland Plc, tel...

Continue reading

iCAD to Present at the 32nd Annual Oppenheimer Healthcare Conference

NASHUA, N.H., March 09, 2022 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company will participate in the virtual 32nd Annual Oppenheimer Healthcare Conference, taking place March 15-17, 2022. Stacey Stevens, President and CEO of iCAD, Inc. is scheduled to present on Thursday, March 17, 2022, at 8:00 a.m. EST. The webcast of this event can be viewed here: https://wsw.com/webcast/oppenheimer20/icad/2709630. About iCAD, Inc. Headquartered in Nashua, NH, iCAD® is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com and www.xoftinc.com. Forward-Looking StatementsCertain statements contained in this News Release constitute “forward-looking...

Continue reading

NTG Nordic Transport Group Annual Report for 2021

Company announcement no. 01 – 229 March 2022 NTG Nordic Transport Group Annual Report for 2021 NTG Nordic Transport Group A/S (“NTG”) has today published the 2021 annual report. Selected financial highlights are presented below:    Full year   Q4(DKKm)   2021 2020   2021 2020Net revenue   7,301.9 5,332.2   2,171.7 1,425.4Gross profit   1,592.1 1,238.4   489.6 349.9Operating profit before special items (adj. EBIT)   542.0 260.7   160.5 82.1Profit for the year   385.3 148.8      Earnings per share (DKK)   15.64 5.61                   Gross margin   21.8% 23.2%   22.5% 24.5%Operating margin   7.4% 4.9%   7.4% 5.8%Conversion ratio   34.0% 21.1%   32.8% 23.5%ROIC before tax   50.8% 34.3%      “2021 was a year of remarkable change. Strong financial performance in both divisions resulted in top line growth...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.